E
CardioComm Solutions, Inc.
EKGGF
$0.0051
-$0.0057-52.78%
E
Sell
8/15/2024Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to E+ from D- on 8/15/2024 due to a major decline in the solvency index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to E+ from D- on 8/15/2024 due to a major decline in the solvency index.
D
Sell
7/9/2024Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D- from E+ on 7/9/2024 due to an increase in the volatility index and total return index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D- from E+ on 7/9/2024 due to an increase in the volatility index and total return index.
E
Sell
6/24/2024Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to E+ from D- on 6/24/2024 due to a substantial decline in the valuation index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to E+ from D- on 6/24/2024 due to a substantial decline in the valuation index.
D
Sell
6/13/2024Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 6/13/2024 due to a noticeable decline in the efficiency index, growth index and total return index. Operating cash flow declined 70.51% from $35.6 to $10.5, and total revenue declined 32.5% from $128.6 to $86.8.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 6/13/2024 due to a noticeable decline in the efficiency index, growth index and total return index. Operating cash flow declined 70.51% from $35.6 to $10.5, and total revenue declined 32.5% from $128.6 to $86.8.
D
Sell
2/2/2024Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 2/2/2024 due to an increase in the volatility index and total return index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 2/2/2024 due to an increase in the volatility index and total return index.
D
Sell
1/18/2024Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 1/18/2024 due to a decline in the volatility index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 1/18/2024 due to a decline in the volatility index.
D
Sell
12/5/2023Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 12/5/2023 due to an increase in the growth index and efficiency index. Total revenue increased 34.53% from $139.6 to $187.8, and EBIT increased 27.54% from -$6.9 to -$5.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 12/5/2023 due to an increase in the growth index and efficiency index. Total revenue increased 34.53% from $139.6 to $187.8, and EBIT increased 27.54% from -$6.9 to -$5.
D
Sell
11/29/2023Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 11/29/2023 due to a decline in the total return index and volatility index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 11/29/2023 due to a decline in the total return index and volatility index.
D
Sell
11/14/2023Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 11/14/2023 due to a noticeable increase in the total return index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 11/14/2023 due to a noticeable increase in the total return index.
D
Sell
9/7/2023Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 9/7/2023 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0001 to $0, net income declined 77.78% from $11.7 to $2.6, and total revenue declined 27.97% from $193.8 to $139.6.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 9/7/2023 due to a significant decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0001 to $0, net income declined 77.78% from $11.7 to $2.6, and total revenue declined 27.97% from $193.8 to $139.6.
D
Sell
11/23/2022Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 11/23/2022 due to a noticeable decline in the total return index and volatility index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 11/23/2022 due to a noticeable decline in the total return index and volatility index.
D
Sell
11/8/2022Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 11/8/2022 due to an increase in the volatility index and total return index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 11/8/2022 due to an increase in the volatility index and total return index.
D
Sell
10/24/2022Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 10/24/2022 due to a decline in the volatility index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 10/24/2022 due to a decline in the volatility index.
D
Sell
10/4/2022Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 10/4/2022 due to a large increase in the valuation index and volatility index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 10/4/2022 due to a large increase in the valuation index and volatility index.
D
Sell
9/19/2022Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 9/19/2022 due to a decline in the volatility index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 9/19/2022 due to a decline in the volatility index.
D
Sell
9/1/2022Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 9/1/2022 due to a substantial increase in the valuation index, growth index and solvency index. Operating cash flow increased 503.86% from -$20.7 to $83.6, EBIT increased 33.01% from $30.9 to $41.1, and debt to equity declined from -1.1 to -1.35.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 9/1/2022 due to a substantial increase in the valuation index, growth index and solvency index. Operating cash flow increased 503.86% from -$20.7 to $83.6, EBIT increased 33.01% from $30.9 to $41.1, and debt to equity declined from -1.1 to -1.35.
D
Sell
6/17/2022Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 6/17/2022 due to a decline in the volatility index and total return index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 6/17/2022 due to a decline in the volatility index and total return index.
D
Sell
6/2/2022Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 6/2/2022 due to a major increase in the efficiency index, growth index and total return index. Total capital increased 320.91% from $11 to $46.3, EBIT increased 71.67% from $18 to $30.9, and total revenue increased 21.15% from $214.2 to $259.5.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 6/2/2022 due to a major increase in the efficiency index, growth index and total return index. Total capital increased 320.91% from $11 to $46.3, EBIT increased 71.67% from $18 to $30.9, and total revenue increased 21.15% from $214.2 to $259.5.
D
Sell
5/4/2022Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 5/4/2022 due to a substantial increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.0003 to $0.0012, operating cash flow increased 298% from -$25 to $49.5, and EBIT increased 154.71% from -$32.9 to $18.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 5/4/2022 due to a substantial increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.0003 to $0.0012, operating cash flow increased 298% from -$25 to $49.5, and EBIT increased 154.71% from -$32.9 to $18.
D
Sell
4/20/2022Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 4/20/2022 due to a major decline in the total return index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 4/20/2022 due to a major decline in the total return index.
D
Sell
11/9/2021Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from E+ on 11/09/2021.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to E+ from D on 11/08/2021.
CardioComm Solutions, Inc. (EKGGF) was downgraded to E+ from D on 11/08/2021.
D
Sell
9/1/2021Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 9/1/2021 due to a major increase in the growth index and solvency index. Operating cash flow increased 33.69% from -$84.9 to -$56.3, debt to equity declined from -0.46 to -0.57, and total revenue increased 17.56% from $106.5 to $125.2.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 9/1/2021 due to a major increase in the growth index and solvency index. Operating cash flow increased 33.69% from -$84.9 to -$56.3, debt to equity declined from -0.46 to -0.57, and total revenue increased 17.56% from $106.5 to $125.2.
D
Sell
8/30/2021Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 8/30/2021 due to a significant decline in the total return index, growth index and solvency index. EBIT declined 498.4% from $12.5 to -$49.8, earnings per share declined from $0.0003 to -$0.0003, and operating cash flow declined 159.63% from -$32.7 to -$84.9.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 8/30/2021 due to a significant decline in the total return index, growth index and solvency index. EBIT declined 498.4% from $12.5 to -$49.8, earnings per share declined from $0.0003 to -$0.0003, and operating cash flow declined 159.63% from -$32.7 to -$84.9.
D
Sell
5/3/2021Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 5/3/2021 due to a decline in the valuation index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 5/3/2021 due to a decline in the valuation index.
D
Sell
3/15/2021Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 3/15/2021 due to a major increase in the total return index and valuation index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 3/15/2021 due to a major increase in the total return index and valuation index.
D
Sell
2/26/2021Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 2/26/2021 due to a decline in the total return index and valuation index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 2/26/2021 due to a decline in the total return index and valuation index.
D
Sell
2/10/2021Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 2/10/2021 due to a significant increase in the total return index and volatility index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 2/10/2021 due to a significant increase in the total return index and volatility index.
D
Sell
12/24/2020Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 12/24/2020 due to a noticeable increase in the solvency index, volatility index and growth index. EBIT increased 351.22% from -$4.1 to $10.3, earnings per share increased from -$0.0002 to -$0.0001, and total revenue increased 7.64% from $129.5 to $139.4.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 12/24/2020 due to a noticeable increase in the solvency index, volatility index and growth index. EBIT increased 351.22% from -$4.1 to $10.3, earnings per share increased from -$0.0002 to -$0.0001, and total revenue increased 7.64% from $129.5 to $139.4.
D
Sell
7/1/2020Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D- from E+ on 7/1/2020 due to an increase in the growth index, volatility index and total return index. EBIT increased 91.91% from -$395.6 to -$32, and earnings per share increased from -$0.0036 to -$0.0004.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D- from E+ on 7/1/2020 due to an increase in the growth index, volatility index and total return index. EBIT increased 91.91% from -$395.6 to -$32, and earnings per share increased from -$0.0036 to -$0.0004.
E
Sell
6/23/2020Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to E+ from D- on 6/23/2020 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0006 to -$0.0054, EBIT declined 616.04% from -$56.1 to -$401.7, and debt to equity increased from -2.1 to -0.57.
CardioComm Solutions, Inc. (EKGGF) was downgraded to E+ from D- on 6/23/2020 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0006 to -$0.0054, EBIT declined 616.04% from -$56.1 to -$401.7, and debt to equity increased from -2.1 to -0.57.
D
Sell
5/29/2020Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 5/29/2020 due to a decline in the volatility index and total return index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 5/29/2020 due to a decline in the volatility index and total return index.
D
Sell
5/11/2020Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 5/11/2020 due to an increase in the growth index, volatility index and valuation index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 5/11/2020 due to an increase in the growth index, volatility index and valuation index.
D
Sell
11/29/2019Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 11/29/2019 due to a noticeable decline in the volatility index, growth index and solvency index. The quick ratio declined from 0.65 to 0.64.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 11/29/2019 due to a noticeable decline in the volatility index, growth index and solvency index. The quick ratio declined from 0.65 to 0.64.
D
Sell
8/30/2019Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 8/30/2019 due to a large increase in the growth index and valuation index. Operating cash flow increased 55.78% from -$50.2 to -$22.2, and earnings per share increased from -$0.0008 to -$0.0007.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 8/30/2019 due to a large increase in the growth index and valuation index. Operating cash flow increased 55.78% from -$50.2 to -$22.2, and earnings per share increased from -$0.0008 to -$0.0007.
D
Sell
5/2/2019Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 5/2/2019 due to a large decline in the growth index and efficiency index. EBIT declined 182.5% from -$48 to -$135.6, net income declined 142.11% from -$70.3 to -$170.2, and earnings per share declined from -$0.0005 to -$0.0012.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 5/2/2019 due to a large decline in the growth index and efficiency index. EBIT declined 182.5% from -$48 to -$135.6, net income declined 142.11% from -$70.3 to -$170.2, and earnings per share declined from -$0.0005 to -$0.0012.
D
Sell
2/25/2019Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 2/25/2019 due to a noticeable increase in the volatility index and total return index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 2/25/2019 due to a noticeable increase in the volatility index and total return index.
D
Sell
1/14/2019Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 1/14/2019 due to a large decline in the total return index and volatility index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 1/14/2019 due to a large decline in the total return index and volatility index.
D
Sell
11/30/2018Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 11/30/2018 due to a noticeable increase in the growth index, efficiency index and valuation index. EBIT increased 65.49% from -$139.1 to -$48, earnings per share increased from -$0.0011 to -$0.0005, and net income increased 52.11% from -$146.8 to -$70.3.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D from D- on 11/30/2018 due to a noticeable increase in the growth index, efficiency index and valuation index. EBIT increased 65.49% from -$139.1 to -$48, earnings per share increased from -$0.0011 to -$0.0005, and net income increased 52.11% from -$146.8 to -$70.3.
D
Sell
8/31/2018Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 8/31/2018 due to a significant decline in the growth index, efficiency index and solvency index. Earnings per share declined from -$0.0004 to -$0.0011, net income declined 161.21% from -$56.2 to -$146.8, and EBIT declined 156.64% from -$54.2 to -$139.1.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D- from D on 8/31/2018 due to a significant decline in the growth index, efficiency index and solvency index. Earnings per share declined from -$0.0004 to -$0.0011, net income declined 161.21% from -$56.2 to -$146.8, and EBIT declined 156.64% from -$54.2 to -$139.1.
D
Sell
5/1/2018Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 5/1/2018 due to a significant decline in the valuation index, volatility index and growth index. Operating cash flow declined 235.85% from -$37.1 to -$124.6.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 5/1/2018 due to a significant decline in the valuation index, volatility index and growth index. Operating cash flow declined 235.85% from -$37.1 to -$124.6.
D
Sell
12/21/2017Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D+ from C- on 12/21/2017 due to a decline in the total return index and volatility index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D+ from C- on 12/21/2017 due to a decline in the total return index and volatility index.
C
Hold
12/6/2017Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to C- from D+ on 12/6/2017 due to a noticeable increase in the volatility index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to C- from D+ on 12/6/2017 due to a noticeable increase in the volatility index.
D
Sell
11/30/2017Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 11/30/2017 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.0001 to $0, the quick ratio increased from 1.04 to 1.08, and debt to equity declined from 1.35 to 1.34.
CardioComm Solutions, Inc. (EKGGF) was upgraded to D+ from D on 11/30/2017 due to a significant increase in the valuation index, growth index and solvency index. Earnings per share increased from -$0.0001 to $0, the quick ratio increased from 1.04 to 1.08, and debt to equity declined from 1.35 to 1.34.
D
Sell
10/16/2017Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 10/16/2017 due to a decline in the volatility index, total return index and efficiency index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D from D+ on 10/16/2017 due to a decline in the volatility index, total return index and efficiency index.
D
Sell
8/31/2017Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to D+ from C- on 8/31/2017 due to a major decline in the efficiency index, total return index and growth index. Earnings per share declined from $0.0001 to -$0.0001, and net income declined 154.91% from $17.3 to -$9.5.
CardioComm Solutions, Inc. (EKGGF) was downgraded to D+ from C- on 8/31/2017 due to a major decline in the efficiency index, total return index and growth index. Earnings per share declined from $0.0001 to -$0.0001, and net income declined 154.91% from $17.3 to -$9.5.
C
Hold
8/8/2017Downgrade
CardioComm Solutions, Inc. (EKGGF) was downgraded to C- from C on 8/8/2017 due to a decline in the total return index.
CardioComm Solutions, Inc. (EKGGF) was downgraded to C- from C on 8/8/2017 due to a decline in the total return index.
C
Hold
7/24/2017Upgraded
CardioComm Solutions, Inc. (EKGGF) was upgraded to C from C- on 7/24/2017 due to a noticeable increase in the total return index and volatility index.
CardioComm Solutions, Inc. (EKGGF) was upgraded to C from C- on 7/24/2017 due to a noticeable increase in the total return index and volatility index.
C
Hold
6/5/2017Upgraded
Cardiocomm Solutions Inc. (EKGGF) was upgraded to C- from D+ on 6/5/2017 due to a major increase in the growth index, total return index and efficiency index. Net income increased 1,541.67% from -$1.2 to $17.3, EBIT increased 950% from -$1.8 to $15.3, and total revenue increased 24.65% from $285.6 to $356.
Cardiocomm Solutions Inc. (EKGGF) was upgraded to C- from D+ on 6/5/2017 due to a major increase in the growth index, total return index and efficiency index. Net income increased 1,541.67% from -$1.2 to $17.3, EBIT increased 950% from -$1.8 to $15.3, and total revenue increased 24.65% from $285.6 to $356.
D
Sell
5/17/2017Upgraded
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D+ from D on 5/17/2017 due to a significant increase in the efficiency index, total return index and volatility index. Total capital increased 64.7% from $286.7 to $472.2.
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D+ from D on 5/17/2017 due to a significant increase in the efficiency index, total return index and volatility index. Total capital increased 64.7% from $286.7 to $472.2.
D
Sell
11/16/2016Upgraded
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D from D- on 11/16/2016 due to an increase in the efficiency index, total return index and volatility index. Net income increased 170.76% from -$17.1 to $12.1, and total capital increased 55.39% from $184.5 to $286.7.
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D from D- on 11/16/2016 due to an increase in the efficiency index, total return index and volatility index. Net income increased 170.76% from -$17.1 to $12.1, and total capital increased 55.39% from $184.5 to $286.7.
D
Sell
6/1/2016Upgraded
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D- from E+ on 6/1/2016 due to an increase in the efficiency index, volatility index and solvency index. Net income increased 90.7% from -$119.3 to -$11.1.
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D- from E+ on 6/1/2016 due to an increase in the efficiency index, volatility index and solvency index. Net income increased 90.7% from -$119.3 to -$11.1.
E
Sell
5/13/2016Downgrade
Cardiocomm Solutions Inc. (EKGGF) was downgraded to E+ from D on 5/13/2016 due to a significant decline in the efficiency index.
Cardiocomm Solutions Inc. (EKGGF) was downgraded to E+ from D on 5/13/2016 due to a significant decline in the efficiency index.
D
Sell
5/2/2016Upgraded
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D from D- on 5/2/2016 due to a significant increase in the efficiency index, growth index and solvency index. Operating cash flow increased 232.2% from $5.9 to $19.6, earnings per share increased from -$0.0013 to -$0.001, and EBIT increased 20.84% from -$151.6 to -$120.
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D from D- on 5/2/2016 due to a significant increase in the efficiency index, growth index and solvency index. Operating cash flow increased 232.2% from $5.9 to $19.6, earnings per share increased from -$0.0013 to -$0.001, and EBIT increased 20.84% from -$151.6 to -$120.
D
Sell
3/11/2016Downgrade
Cardiocomm Solutions Inc. (EKGGF) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index. Debt to equity increased from -1.88 to -1.86.
Cardiocomm Solutions Inc. (EKGGF) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index, total return index and solvency index. Debt to equity increased from -1.88 to -1.86.
D
Sell
6/2/2015Downgrade
Cardiocomm Solutions Inc. (EKGGF) was downgraded to D from D+ on 6/2/2015 due to a noticeable decline in the growth index, solvency index and valuation index. Operating cash flow declined 170.84% from $164.6 to -$116.6, earnings per share declined from -$0.0005 to -$0.0003, and debt to equity increased from -1.71 to -2.04.
Cardiocomm Solutions Inc. (EKGGF) was downgraded to D from D+ on 6/2/2015 due to a noticeable decline in the growth index, solvency index and valuation index. Operating cash flow declined 170.84% from $164.6 to -$116.6, earnings per share declined from -$0.0005 to -$0.0003, and debt to equity increased from -1.71 to -2.04.
D
Sell
5/15/2015Downgrade
Cardiocomm Solutions Inc. (EKGGF) was downgraded to D+ from C on 5/15/2015 due to a significant decline in the efficiency index.
Cardiocomm Solutions Inc. (EKGGF) was downgraded to D+ from C on 5/15/2015 due to a significant decline in the efficiency index.
C
Hold
5/1/2015Upgraded
Cardiocomm Solutions Inc. (EKGGF) was upgraded to C from D on 5/1/2015 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 217.8% from $150 to $476.7, and debt to equity declined from -1.78 to -0.03.
Cardiocomm Solutions Inc. (EKGGF) was upgraded to C from D on 5/1/2015 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 217.8% from $150 to $476.7, and debt to equity declined from -1.78 to -0.03.
D
Sell
9/4/2014Downgrade
Cardiocomm Solutions Inc. (EKGGF) was downgraded to D from D+ on 9/4/2014 due to a significant decline in the growth index. Total revenue declined 43.11% from $464.4 to $264.2.
Cardiocomm Solutions Inc. (EKGGF) was downgraded to D from D+ on 9/4/2014 due to a significant decline in the growth index. Total revenue declined 43.11% from $464.4 to $264.2.
D
Sell
6/4/2014Upgraded
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D+ from D on 6/4/2014 due to a substantial increase in the growth index, valuation index and total return index. Total revenue increased 275.73% from $123.6 to $464.4.
Cardiocomm Solutions Inc. (EKGGF) was upgraded to D+ from D on 6/4/2014 due to a substantial increase in the growth index, valuation index and total return index. Total revenue increased 275.73% from $123.6 to $464.4.
OTC PK
03/10/2025 2:31PM Eastern
Quotes delayed
